Raymond James Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,891
Closed -$472K 758
2016
Q4
$472K Sell
5,891
-145
-2% -$11.5K 0.04% 364
2016
Q3
$481K Sell
6,036
-20,821
-78% -$1.68M 0.04% 345
2016
Q2
$2.09M Buy
26,857
+964
+4% +$68.7K 0.18% 123
2016
Q1
$1.42M Buy
25,893
+172
+0.7% +$9.37K 0.13% 159
2015
Q4
$1.59M Sell
25,721
-1,154
-4% -$72.8K 0.15% 148
2015
Q3
$1.7M Sell
26,875
-22
-0.1% -$1.57K 0.19% 122
2015
Q2
$1.97M Sell
26,897
-256
-0.9% -$18.5K 0.21% 115
2015
Q1
$1.78M Sell
27,153
-544
-2% -$36.2K 0.19% 126
2014
Q4
$1.8M Buy
27,697
+23
+0.1% +$1.48K 0.19% 125
2014
Q3
$1.66M Sell
27,674
-1,002
-3% -$65.5K 0.19% 119
2014
Q2
$1.99M Sell
28,676
-655
-2% -$42.5K 0.23% 103
2014
Q1
$1.92M Buy
29,331
+2,308
+9% +$150K 0.24% 101
2013
Q4
$1.67M Buy
27,023
+2,155
+9% +$125K 0.22% 109
2013
Q3
$1.33M Sell
24,868
-590
-2% -$30.4K 0.21% 124
2013
Q2
$1.16M Buy
+25,458
New +$1.1M 0.19% 130

Other funds holding STJ

Raymond James Trust's STJ Position: Q1 2017 in Review

Raymond James Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 5,891 shares — an estimated $472K sold.

Raymond James Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.09M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Raymond James Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Raymond James Trust sold 5,891 St Jude Medical shares in Q1 2017, an estimated $472K.
  • Raymond James Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Raymond James Trust's St Jude Medical position peaked at $2.09M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Raymond James Trust's 13F filing for Q1 2017, filed 7 Apr 2017.